Riskpilot← Back to searchSign inGet full accessAlpha Vitae AB
ABActiveOrg 5566691985Lilla Fiskaregatan 10Other education n.e.c. · NACE 8559Est. 20041-4 employees
Revenue 2024
SEK 730K
-6% vs 2023
EBITDA margin
-1.8%
-116% vs 2023
Equity ratio
60.2%
Financial strength
Net profit 2024
SEK -13K
-121% vs 2023
| Revenue | SEK 730K | -6% |
| EBITDA | SEK -13K | -116% |
| Net profit | SEK -13K | -121% |
| Total assets | SEK 354K | -32% |
| Equity | SEK 213K | -6% |
| Employees | — | — |
Legal name
Alpha Vitae AB
Org number
5566691985
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
26 oktober 2004
Share capital
SEK 102 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva företagshälsovård och tillhandahålla tjänster inom arbetsmiljöområdet samt därmed förenlig verksamhet.
Address
Lilla Fiskaregatan 10
Email
info@alphavitae.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 621 | 715 | 798 | 777 | 730 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −48 | 86 | 62 | 82 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −48 | 86 | 62 | 82 | −13 |
| Net financials | — | −1 | −1 | −2 | −1 |
| Profit before tax | −48 | 85 | 62 | 81 | −13 |
| Tax | −0 | −10 | −14 | −18 | −0 |
| Net profit | −48 | 75 | 48 | 63 | −13 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 288 | 355 | 430 | 522 | 354 |
| Equity | 80 | 156 | 203 | 227 | 213 |
| Long-term debt | 150 | 150 | 161 | 142 | 80 |
| Short-term debt | 58 | 49 | 66 | 154 | 60 |
| Total debt | 208 | 199 | 227 | 296 | 140 |
EBITDA margin
-1.8%
This company
15.8%
Market median
-111% vs market
20202024
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
-6.1%
This company
18.4%
Market median
-133% vs market
20202024
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
20202024
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
KJ Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alpha Vitae AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| C Jeanette E S Brugge Welin | Chief Executive Officer | 0 companies |
| Kim Jeanette Månsson | Audit | 0 companies |
| Marica Cecilia Stigsdotter Lundahl | Chairman | 0 companies |
| Per Ola Carsten Lundahl | Deputy Board Member | 0 companies |
| Anders Göran Eson Welin | Deputy Board Member | 0 companies |